Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
144
Filing Date
3/2/2025
Updated
3/3/25, 2:09 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities